Any retatrutide obtained outside of a formal, ethics-approved clinical trial is classified as a research chemical and is not intended for human use under current UK regulations
This may include people with active cancer concerns, immune disorders, uncontrolled chronic illness, pregnancy or plans for pregnancy, complex medication regimens, bleeding disorders, severe allergies, kidney or liver concerns, unexplained symptoms, or a history of poor reactions to injectable products
Simply the best
Montgomery et al., 2025)
Current Europe research demonstrates potential benefits of BPC-157 for tendon injuries, tendon outgrowth, bone healing, and joint health, in addition to reducing inflammatory responses and tissue damage
If so then no they are not curbing my appetite